En Es
Categorías

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology. The company’s products detect multi-pathogens with high sensitivity, specificity and reproducibility, resulting in saving of time, labor and cos ...
Miembro Oro
Productos Covid-19NoticiasResumen
Close

Covid-19 Seegene

Laboratorio clínico

ENSAYO PARA VARIANTES DEL SARS-COV-2
Allplex SARS-CoV-2 Variants II Assay

El ensayo Allplex SARS-CoV-2 Variants II esta diseñado para la detección simultánea de cuatro sitios de mutación en el gen S para la identificación de variantes del SARS-CoV-2.
Mas detalles

SARS-CoV-2 Variants Assay
Novaplex SARS-CoV-2 Variants IV Assay

The Novaplex SARS-CoV-2 Variants IV Assay is a real-time reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the qualitative detection and differentiation of SARS-CoV-2 viral nucleic acids and Delta variants. The multiplex real-time PCR assay is designed to detect and differentiate mutations in a single tube, and is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.
Mas detalles

Liquid Handling Workstation
AdvanSure E3 SYSTEM

The AdvanSure E3 SYSTEM is an easy-to-use liquid handling workstation for handling primary sample tube to nucleic acid (NA) extraction. It provides a convenient process for your laboratory workflow by minimizing hands-on time and maximizing assay reliability.
Mas detalles

ENSAYO DE VARIANTES DEL SARS-COV-2
Allplex SARS-CoV-2 Variants I Assay

El ensayo Allplex SARS-CoV-2 Variants I está destinado a la detección y diferenciación de tres sitios de mutación en el gen S para la identificación de variantes del SARS-CoV-2.
Mas detalles

SARS-CoV-2 Master Assay
Allplex SARS-CoV-2 Master Assay

The Allplex SARS-CoV-2 Master Assay is intended for the full screening for SARS-CoV-2 and variants, including the five notable mutations in the S gene. It can be used alone or expanded to syndromic test with respiratory essential panel for common respiratory infections, including influenza A and B, metapneumovirus, parainfluenza virus 1/2/3/4, adenovirus, rhinovirus A/B/C and respiratory syncytial virus A/B, to provide more insights for diagnosis of symptomatic patients, especially with the emerging SARS-CoV-2 variants.
Mas detalles

PRUEBA DE PCR PARA EL SARS-COV
Allplex 2019-nCoV Assay

El ensayo Allplex 2019-nCoV es un ensayo de PCR en tiempo real multiplex para la detección simultánea de tres genes objetivo del SARS-CoV-2 en un solo tubo. El ensayo fue diseñado para detectar genes RdRP y N específicos para el SARS-CoV-2.
Mas detalles

PRUEBA DE SARS-COV-2
Allplex SARS-CoV-2 Assay

Análisis Allplex SARS-CoV-2, ensayo de PCR multiplex en tiempo real, detecta cuatro genes diana del SARS-CoV-2, en un solo tubo. Aplicable en el sistema automatizado Seegene, permite realizar pruebas de alto rendimiento.
Mas detalles

SARS-CoV-2/FluA/FluB/RSV Test
Allplex SARS-CoV-2/FluA/FluB/RSV Assay

The Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay is a multiplex real-time PCR assay designed to detect N gene, RdRP gene and S gene for SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) A/B in a single tube. The assay is applied on Seegene’s integrated All-in-One automated platform which enables high-throughput testing.
Mas detalles
Close

Noticias of Seegene

Seegene Unveils Combination Test at ECCMID 2018

19 Apr 2018
Seegene Unveils Combination Test at ECCMID 2018
Seegene Inc., a developer of multiplex PCR technologies, introduced a combination test at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) held in Madrid, Spain, from April 21 to 24, 2018. The combination test is a high-efficiency solution that diagnoses various causes of diseases with multiplex molecular diagnosis assays. Seegene also showcased its molecular diagnostic system SGSTAR (Seegene Sameday Test and Report), which allows order-to-report on the same day and enables the running of the combination test.
Más info

Seegene Develops World’s First Multiplex MDx Assays with AI System

09 Jan 2018
Seegene Develops World’s First Multiplex MDx Assays with AI System
Seegene Inc., a developer of multiplex PCR technologies, successfully developed molecular diagnostics (MDx) assays in just four days using an artificial intelligence- (AI) based automated assay development system. These assays are high multiplex real-time PCR reagents developed completely by AI and are meant for the simultaneous detection of eight different DNA targets for each of meningitis and sexually transmitted infections.
Más info

Seegene Partners with Hamilton to Develop Random Access System

28 Sep 2017
Seegene Partners with Hamilton to Develop Random Access System
Seegene, a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics (M-MoDx), has signed a Memorandum of Understanding (MoU) with Hamilton Company, which designs and manufactures precision measurement devices, automated liquid handling workstations, and sample management systems, to develop the Seegene Random Access System.
Más info

Seegene Collaborates with Thermo to Enter US Market

29 May 2017
Seegene Collaborates with Thermo to Enter US Market
Seegene Inc., a developer of multiplex molecular diagnostics technologies and assays, has entered into a collaboration with Thermo Fisher Scientific, in which Seegene will file for U.S. Food and Drug Administration (FDA) clearance of its Allplex diagnostic assay portfolio at the same time that Thermo Fisher files for FDA clearance to run Seegene's assays on Thermo Fisher's QuantStudio 5 Real-Time PCR System (PCR System).
Más info
Close

Sobre Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for infectious diseases, genetics, pharmacogenetics, and oncology. The company’s products detect multi-pathogens with high sensitivity, specificity and reproducibility, resulting in saving of time, labor and cost.
Facebook Twitter Google+ Linked in
SOLUCIÓN TODO EN UNO PARA TODAS LAS PRUEBAS MOLECULARES

SOLUCIÓN TODO EN UNO PARA TODAS LAS PRUEBAS MOLECULARES

Modelo: STARlet-AIOS
Solicite información

Descripción:

La solución todo en uno STARlet-AIOS para pruebas moleculares es un sistema de PCR completamente automatizado (MDx) que proporciona flujo de trabajo de PCR en tiempo real de alto rendimiento desde la extracción de ácido nucleico hasta la interpretación de resultados.


Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
Seegene (SOLUCIÓN TODO EN UNO PARA TODAS LAS PRUEBAS MOLECULARES)
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones